Center of Psychotherapy, Psychosomatics and Psychedelic Medicine Expio

Opening Hours : Mon-Fri 10.00 - 19.00.

Tel. +380 7373 080 88

All posts by Center Expo

минвет

Cooperation with the Ministry of Veterans of Ukraine

Press release
Міністерство у справах ветеранів в особі Міністра у справах ветеранів України, Наталії Калмикової та Медичний центр ТОВ Експіо в особі директора Владислава Матреницького підписали Меморандум про співпрацю для досягнення спільної мети: підтримки громадян України, які постраждали внаслідок війни та військових дій.
Read More
2025-03-22_180105

Ketamine treatment helped many US veterans with severe depression and PTSR

Ketamine is gaining more and more attention as a promising treatment for depression. However, few studies have yet analyzed its effectiveness in real clinical conditions, especially in patients with complex mental disorders.

A new study based on veterans data, which repeatedly tried to treat depression but remained with severe symptoms, showed that the course of intravenous ketamine infusions helped many patients. In some cases, even complete remission has been achieved.

Read More
ketamine-session2-med

The Center for Expio begins a clinical study of the effect of ketamine-assistant psychotherapy on veterans with PTSD resistant to treatment

Press release

Studies show that the prevalence of post -traumatic stress disorder (PTSD) in veterans
is 15-20% or more, plus in half of sick together with PTSD also there is a large
Depressive disorder. Meanwhile, traditional first -line treatment (antidepressants and psychotherapy)
It is only effective in about 40% of veterans.

These data emphasize the urgent need for new effective treatments for this disorder. Exactly
Therefore, Expio Medical Center, a leading organization in the development of the latest recovery methods
mental health, begins researching a new method that has already shown its effectiveness in
clinical conditions in our center and abroad:

“Monocenteral randomized double-blind controlled clinical examination of ketamine-assistent integrative psychotherapy in veterans with post -traumatic treatment resistant to
stress disorder (PTSD) ”.

Read More
depression-migraine

It turns out that migraine and depression have common mechanisms of occurrence

Migraine and depression are closely interconnected, and this bond is much more complicated than simply "chronic pain impairs mood". New studies show that if a person suffers from migraines, then his risk of depression increases 2.5 times! But the most interesting thing is that this connection is bilateral: depression also increases the likelihood of migraine, and also contributes to the fact that headaches become chronic and more difficult to treat.

Read More
women-in-depression

How can ketamine help fight depressive beliefs?

Our brain constantly creates beliefs - about itself, about the world, about the future. They help us navigate reality. But in depression, this mechanism fails: negative thoughts are fixed, and it seems that it is impossible to change them.

And what if there was a way to restart this process?

Read More
traumatic-brain-injury

Can psychedelics help with brain injury recovery?

In a world where brain injuries and strokes remain one of the main causes of disability, the search for new treatments is not just relevant but critical. Traditional rehabilitation methods have their restrictions, and pharmacological approaches often do not produce the expected result or are accompanied by significant side effects. However, a new player appears on the horizon, who began to be considered not only as a means of expanding consciousness, but also as potential therapeutic tools.

Read More
psy_vets

Research and Implementation of Psychedelic Therapy in the Veterans Health Care System

In recent years, psychedelics have gained renewed attention as potential tools for the treatment of various mental disorders, particularly among veterans who face unique psychological challenges. Article “Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration” (Research and Implementation of Psychedelic Therapy in the Veterans Health Care System), published in the American Journal of Psychiatry, offers an in-depth review of how these substances can be integrated into the health care system of veterans suffering from PTSD. disorder (PTSD), depression and other mental disorders.

Read More
2025-01-04_175419

Ketamine can overcome the dyskinesias that occur in the treatment of Parkinson's disease

Researchers from Arizona University have revealed a new understanding of one of the most common complications faced by patients with Parkinson's disease: uncontrolled movements that occur after years of treatment.

Parkinson's disease - a neurological disorder of the brain, which affects human movements - develops when the level of dopamine, the chemical in the brain responsible for the movement of the body begins to decrease.

To prevent dopamine loss, a drug called Levodopa is introduced, which is later converted to dopamine into a brain. However, prolonged treatment with levodopa causes involuntary and uncontrolled movements known as dyskinesia caused by levodopa.

A study published in a journal Brain, It has found new discoveries about the nature of dyskinesia caused by levodopa, and how ketamine, anesthetic, can help solve this complex condition.

Read More